Androgen-deprivation therapy in prostate cancer and cardiovascular risk

A science advisory from the American heart association, American cancer society, and American urological association

Glenn N. Levine, Anthony V. D'Aamico, Peter Berger, Peter E. Clark, Robert H. Eckel, Nancy L. Keating, Richard V. Milani, Arthur I Sagalowsky, Matthew R. Smith, Neil Zakai

Research output: Contribution to journalArticle

190 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)833-840
Number of pages8
JournalCirculation
Volume121
Issue number6
DOIs
StatePublished - Feb 2010

Fingerprint

American Heart Association
Androgen Antagonists
Medical Societies
Advisory Committees
Gonadotropin-Releasing Hormone
Androgens
Prostatic Neoplasms
Cardiovascular Diseases
Therapeutics

Keywords

  • AHA Scientific Statements
  • Androgen-deprivation therapy
  • Cardiovascular risk
  • Prostate cancer

ASJC Scopus subject areas

  • Physiology (medical)
  • Cardiology and Cardiovascular Medicine

Cite this

Androgen-deprivation therapy in prostate cancer and cardiovascular risk : A science advisory from the American heart association, American cancer society, and American urological association. / Levine, Glenn N.; D'Aamico, Anthony V.; Berger, Peter; Clark, Peter E.; Eckel, Robert H.; Keating, Nancy L.; Milani, Richard V.; Sagalowsky, Arthur I; Smith, Matthew R.; Zakai, Neil.

In: Circulation, Vol. 121, No. 6, 02.2010, p. 833-840.

Research output: Contribution to journalArticle

Levine, Glenn N. ; D'Aamico, Anthony V. ; Berger, Peter ; Clark, Peter E. ; Eckel, Robert H. ; Keating, Nancy L. ; Milani, Richard V. ; Sagalowsky, Arthur I ; Smith, Matthew R. ; Zakai, Neil. / Androgen-deprivation therapy in prostate cancer and cardiovascular risk : A science advisory from the American heart association, American cancer society, and American urological association. In: Circulation. 2010 ; Vol. 121, No. 6. pp. 833-840.
@article{ccf53adf4f6644adb18214d7d2f8ecb3,
title = "Androgen-deprivation therapy in prostate cancer and cardiovascular risk: A science advisory from the American heart association, American cancer society, and American urological association",
keywords = "AHA Scientific Statements, Androgen-deprivation therapy, Cardiovascular risk, Prostate cancer",
author = "Levine, {Glenn N.} and D'Aamico, {Anthony V.} and Peter Berger and Clark, {Peter E.} and Eckel, {Robert H.} and Keating, {Nancy L.} and Milani, {Richard V.} and Sagalowsky, {Arthur I} and Smith, {Matthew R.} and Neil Zakai",
year = "2010",
month = "2",
doi = "10.1161/CIRCULATIONAHA.109.192695",
language = "English (US)",
volume = "121",
pages = "833--840",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Androgen-deprivation therapy in prostate cancer and cardiovascular risk

T2 - A science advisory from the American heart association, American cancer society, and American urological association

AU - Levine, Glenn N.

AU - D'Aamico, Anthony V.

AU - Berger, Peter

AU - Clark, Peter E.

AU - Eckel, Robert H.

AU - Keating, Nancy L.

AU - Milani, Richard V.

AU - Sagalowsky, Arthur I

AU - Smith, Matthew R.

AU - Zakai, Neil

PY - 2010/2

Y1 - 2010/2

KW - AHA Scientific Statements

KW - Androgen-deprivation therapy

KW - Cardiovascular risk

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=77149172555&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77149172555&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.109.192695

DO - 10.1161/CIRCULATIONAHA.109.192695

M3 - Article

VL - 121

SP - 833

EP - 840

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 6

ER -